Empfield James R.'s Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Aug 16, 2022
- Accession no.
- 0001209191-22-046017
- Filed
- Aug 16, 2022
- Trade date
- Aug 12, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.21M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Empfield James R.CIK 0001665430 | Officer (EVP, Drug Discovery) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Shares | MOption exerciseAcquired | +20,000 | $3.10 | +$62,000 | 30,000 | Direct | |
| Aug 12, 2022 | Common Shares | MOption exerciseAcquired | +45,000 | $4.75 | +$213,750 | 75,000 | Direct | |
| Aug 12, 2022 | Common Shares | FTax withholdingDisposed | −7,257 | $38.02 | −$275,911.14 | 67,743 | Direct | |
| Aug 12, 2022 | Common Shares | SSaleDisposed | −35,868 | $38.08 | −$1,365,853.44 | 31,875 | Direct | |
| Aug 12, 2022 | Common Shares | SSaleDisposed | −21,875 | $38.68 | −$846,125 | 10,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Shares | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct | |
| Aug 12, 2022 | Common Shares | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.